BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20142544)

  • 1. Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients.
    Hara R; Kawaji T; Ando E; Ohya Y; Ando Y; Tanihara H
    Arch Ophthalmol; 2010 Feb; 128(2):206-10. PubMed ID: 20142544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy.
    Sandgren O; Kjellgren D; Suhr OB
    Acta Ophthalmol; 2008 Aug; 86(5):520-4. PubMed ID: 18435819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostaining images of vitreous transthyretin amyloid.
    Latasiewicz M; Adan A; Solé M
    Can J Ophthalmol; 2015 Oct; 50(5):384-7. PubMed ID: 26455975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthyretin-related vitreous amyloidosis in different endemic areas.
    Kawaji T; Ando Y; Ando E; Sandgren O; Suhr OB; Tanihara H
    Amyloid; 2010 Sep; 17(3-4):105-8. PubMed ID: 21077797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of liver transplantation on the natural history of oculopathy in Portuguese patients with transthyretin (V30M) amyloidosis.
    Beirão JM; Malheiro J; Lemos C; Matos E; Beirão I; Pinho-Costa P; Torres P
    Amyloid; 2015 Mar; 22(1):31-5. PubMed ID: 25475560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manifestations of transthyretin-related familial amyloidotic polyneuropathy: long-term follow-up of Japanese patients after liver transplantation.
    Ohya Y; Okamoto S; Tasaki M; Ueda M; Jono H; Obayashi K; Takeda K; Okajima H; Asonuma K; Hara R; Tanihara H; Ando Y; Inomata Y
    Surg Today; 2011 Sep; 41(9):1211-8. PubMed ID: 21874417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin.
    Munar-Qués M; Salva-Ladaria L; Mulet-Perera P; Solé M; López-Andreu FR; Saraiva MJ
    Amyloid; 2000 Dec; 7(4):266-9. PubMed ID: 11132095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary glaucoma in patients with familial amyloidotic polyneuropathy.
    Kimura A; Ando E; Fukushima M; Koga T; Hirata A; Arimura K; Ando Y; Negi A; Tanihara H
    Arch Ophthalmol; 2003 Mar; 121(3):351-6. PubMed ID: 12617705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
    Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
    Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases.
    Beirão JM; Malheiro J; Lemos C; Beirão I; Costa P; Torres P
    Amyloid; 2015; 22(2):117-22. PubMed ID: 26096568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of familial amyloid polyneuropathy due to Phe33Val TTR with vitreous involvement as the initial manifestation.
    Kono S; Manabe Y; Tanaka T; Fujii D; Sakai Y; Narai H; Omori N; Ueda M; Ando Y; Abe K
    Intern Med; 2010; 49(12):1213-6. PubMed ID: 20558946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retinal laser photocoagulation for familial transthyretin-related ocular amyloidosis].
    Kawaji T
    Nippon Ganka Gakkai Zasshi; 2012 Nov; 116(11):1046-51. PubMed ID: 23316653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ocular involvement in familial amyloid polyneuropathy].
    Rousseau A; Kaswin G; Adams D; Cauquil C; Théaudin M; Mincheva Z; M'garrech M; Labetoulle M; Barreau E
    J Fr Ophtalmol; 2013 Nov; 36(9):779-88. PubMed ID: 24144522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreous surgery impact in glaucoma development in liver transplanted familial amyloidosis ATTR V30M Portuguese patients.
    Beirão NM; Matos ME; Meneres MJ; Beirão IM; Costa PP; Torres PA
    Amyloid; 2012 Sep; 19(3):146-51. PubMed ID: 22856884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elderly onset vitreous opacities as the initial manifestation in hereditary transthyretin (ATTR Val30Met) carries.
    Ishida K; Nishida T; Niimi Y; Suemori S; Mochizuki K; Kawakami H; Kimura A; Hirayama T
    Ophthalmic Genet; 2017; 38(4):387-391. PubMed ID: 28085522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 25-gauge vitrectomy to treat ocular complications of familial amyloid polyneuropathy.
    Miyahara T; Ohta K; Yamamoto Y; Ueno A; Murata T
    J Glaucoma; 2007 Jan; 16(1):169-70. PubMed ID: 17224769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RE-INTERVENTION IN DE NOVO VITREOUS OPACITIES AFTER PARS PLANA VITRECTOMY IN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY TTR VAL30METPORTUGUESE PATIENTS.
    Ferreira NN; Cunha Dias DA; Afonso Carvalho RP; Pardal Monteiro Coelho MT
    Retin Cases Brief Rep; 2019 Summer; 13(3):273-278. PubMed ID: 28333852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of vitreous amyloidosis and need of surgical reintervention in Portuguese patients with familial amyloidosis ATTR V30M.
    Beirão NM; Matos E; Beirão I; Costa PP; Torres P
    Retina; 2011; 31(7):1373-7. PubMed ID: 21358362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis.
    Buxbaum JN; Brannagan T; Buades-Reinés J; Cisneros E; Conceicao I; Kyriakides T; Merlini G; Obici L; Plante-Bordeneuve V; Rousseau A; Sekijima Y; Imai A; Waddington Cruz M; Yamada M
    Amyloid; 2019 Mar; 26(1):10-14. PubMed ID: 30675806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapy for transthyretin-related ocular amyloidosis: a pilot study of retinal laser photocoagulation.
    Kawaji T; Ando Y; Hara R; Tanihara H
    Ophthalmology; 2010 Mar; 117(3):552-5. PubMed ID: 20045573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.